Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 2, 2009, Pages 630-639

  Kanojia, Deepika ^a   Garg, Manoj ^a   Gupta, Samir ^b   Gupta, Anju ^c   Suri, Anil ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b ARMY HOSPITAL   (India)

^c Moolchand Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN SPAG9; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHI-SQUARE DISTRIBUTION; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM RECURRENCE, LOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 60549091726     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0629     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Sheshadri HS, Kandaswamy A. Computer aided decision system for early detection of breast cancer. Indian J Med Res 2006;124:149-54.
3. Smith RA, Caleffi M, Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J 2006;12:S16-26.
4. Fernandez-Madrid F. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer Lett 2005;230:187-98.
5. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25:5287-312.
6. Suri A. Cancer testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther 2006;6:379-89.
7. Lechpammer M, Lukac J, Lechpammer S, Kovacevic D, Loda M, Kusic Z. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy. Int J Colorectal Dis 2004;19:114-20.
8. Casiano CA, Varela MM, Tan EM. Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics 2006;5:1745-59.
9. Scanlan MJ, Simpson AJG, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004;4:1.
10. Stockert E, Jager E, Chen YT, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998;187:1349-54.
11. Mischo A, Kubuschok B, Ertan K, et al. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer. Int J Cancer 2006;118:696-703.
12. Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res 2007;13:1421-28.
13. Willis S, Hutchins AM, Hammet F, et al. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers. Genes Chromosomes Cancer 2003;36:382-92.
14. Kobayashi T, Masumoto J, Tada T, Nomiyama T, Hongo K, Nakayama J. Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas. Clin Cancer Res 2007;13:3868-74.
15. Jagadish N, Rana R, Selvi R, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology withc-Jun N-terminal kinase-interacting protein. Biochem J 2005;389:73-82.
16. Jagadish N, Rana R, Mishra D, Garg M, Selvi R, Suri A. Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9). Vaccine 2006;24:3695-703.
17. Adjuvant! Online software. Available from: https://www.adjuvan-tonline. com.
18. Shetty A, Loddo M, Fanshawe T, et al. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer 2005;93:1295-300.
19. Chapman C, Murray A, Chakrabarti J, et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 2007;18:868-73.
20. Sugita Y, Wada H, Fujita S, et al. NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer Res 2004;64:2199-204.
21. Duffy MJ. Serum tumor markers in breast cancer: are they of clinical value? Clin Biochem 2006;52:345-51.
22. Cressey R, Pimpa S, Chewaskulyong B, et al. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients. BMC Biotechnol 2008;8:16.
23. Tomkiel JE, Alansari H, Tang N, et al. Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer. Clin Cancer Res 2002;8:752-8.
24. Fernandez-Madrid F, Tang N, Alansari H, et al. Autoantibodies to Annexin XIA and other autoantigens in the diagnosis of breast cancer. Cancer Res 2004;64:5089-96.
25. Garg M, Kanojia D, Khosla A, et al. Sperm-associated antigen 9 is associated withtumor growth, migration, and invasion in renal cell carcinoma. Cancer Res 2008;68:8240-8.
26. Shankar S, Mohapatra B, Suri A. Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif. Biochem Biophys Res Commun 1998;243:561-5.
27. Lee CL, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: A scaffolding protein that tethers JNK/p38 MAPK signaling modules and transcriptionfactors. Proc Natl Acad Sci US A2002;99:14189-94.
28. Qi M, Elion EA. MAP kinase pathways. J Cell Sci 2005;118:3569-72.
29. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene 2007;26:3185-202.
30. Willoughby EA, Collins MK. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein β-arrestin 2. J Biol Chem 2005;280:25651-8.
31. Kelkar N, Standen CL, Davis RJ. Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol Cell Biol 2005;25:2733-43.
32. Kashef K, Xu H, Reddy P, Dhanasekaran DN. Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. J Cell Biochem 2006;98:715-22.
33. Bandic D, Juretic A, Sarcevic B, et al. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women withrelapsing invasive ductal breast cancer: retrospective immunohistochemical study. Croat Med J 2006;47:34-41.
34. Kruger S, Ola V, Feller AC, Fischer D, Friedrich M. Expression of cancer-testis antigen CT7 (MAGE-C1) in breast cancer: an immuno- histochemical study with emphasis on prognostic utility. Pathol Oncol Res 2007;13:91-6.
35. Yang X, Groshen S, Formenti AC, Davidson NE, Press MF. P7 antigen expression in human breast cancer. Clin Cancer Res 2003;9:201-6.
36. Pandya AY, Talley LI, Frost AR, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res 2004;10:2709-19.
37. Keyomarsi K, Tucker SL, Buchholz TA, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347:1566-75.
38. Parmigiani RB, Bettoni F, Vibranovski MD, et al. Characterization of a cancer-testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc Natl Acad Sci USA 2006;103:18066-71.
39. Wei CL, Wu Q, Vega SV, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006;124:207-19.